- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
Experts weigh benefits, risks of Allergan-Inamed merger
National report — A proposed $3.2 billion merger of Botox-maker Allergan and breast-implant maker Inamed would ultimately benefit dermatologists, an Allergan official says.
Related Videos
How Mindy Haws, MD, Empowers Women in Aesthetic Medicine
LIMITLESS: A Collaborative Effort Between Allergan, The Aesthetic Society, and The American Society of Plastic Surgeons
How the LIMITLESS Initiative Supports Female Leaders in Dermatology
Aesthetic Treatments: More Than Just Enhancements, A Path to Empowerment
Four Key Factors When Buying Dermatology Devices
Chilukuri’s Approach to Safer Aesthetic Treatments
Zoe Diana Draelos, MD, Talks Cosmeceuticals at Fall Clinical
Matt Leavitt Shares His Pearls for Hair Loss Treatments at Fall Clinical
Tina Alster, MD, Receives Vic Narurkar Aesthetic Lectureship in Aesthetic Innovations
Pointers With Dr Portela: Oral Minoxidil For Hair Loss
Related Content
